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Abstract 
Background: Open or laparoscopic surgical exploration of common bile duct (CBD) is performed when endoscopic 
approaches fail to extract CBD stones. Intraoperative cholangiography (IOC) through T-tube is performed in order to 
reduce the rate of retained stones. The aim of this study was to evaluate results of CBD exploration without IOC through 
T-tube and reviewing existing literature.
Methods: A retrospective medical chart review of 392 patients who underwent surgical CBD exploration was 
performed. All patients had proven CBD stones and had previously undergone failed attempts of endoscopic retrograde 
cholangiopancreatography (ERCP) and endoscopic sphincterotomy (ES). T-tube insertion or biliary-enteric anastomosis 
was performed after open CBD exploration with regard to patient’s presentation and CBD diameter. IOC was not 
performed after T-tube insertion and cholangiography was postponed until 7th postoperative day. Postoperative retained 
stone and their management were reviewed.
Results: Of 392 patients with CBD explorations, T-tube was placed in 215 (54.8%) including 66 (30.7%) emergent 
biliary drainage and 149 (69.3%) elective operations. A number of 177 of 392 (45.2%) patients underwent biliary-
enteric anastomosis. In 6 of 215 patients (2.8%) with T-tube placement, retained CBD stones were detected by T-tube 
cholangiography during postoperative period. All of them were treated successfully by ERCP.
Conclusions: T-tube placement without IOC is accompanied by a low rate of retained stone. Omitting IOC may 
decrease the operation time which is especially important in emergent cases. Retained stones following CBD exploration 
and T-tube placement can be treated successfully using ERCP.
Citation: Shojaiefard A, Khorgami Zh, Ghafouri A, Soroush A, Hedayat A, Kaveie E, Ghazi-Nezami B. Outcome of 
Common Bile Duct Exploration without Intraoperative Cholangiography: a Case Series and Review of 
Literature. Acad J Surg, 2014; 1(3-4): 60-65.
Keywords: Common Bile Duct, Cholangiography, Cholangiopancreatography (ERCP), Endoscopic Retrograde, 
Sphincterotomy, Endoscopic, Gallstones. 
Introduction 
The ideal treatment for common bile duct (CBD) 
stones remains controversial with options ranging from 
single staged open or laparoscopic CBD exploration to 
two-stage endoscopic retrograde cholangio- 
pancreatography (ERCP), endoscopic sphincterotomy 
(ES) and cholecystectomy (1). 
The open approach for CBD exploration is still 
indicated despite introduction of endoscopic and 
laparoscopic methods (2). It is performed in emergent 
situations (such as presence of severe necrotizing 
pancreatitis, and deteriorating acute cholangitis) when 
laparoscopic and endoscopic approaches fail, when 
laparoscopic approach is impossible or difficult (due to 
previous surgery and extensive adhesions) and finally, 
unavailability of equipment and insufficient expertise 
for laparoscopic or endoscopic approaches. Thus, 
taking into consideration the ongoing application of 
open approach, further investigations on this approach 
seems to be mandatory to obviate its shortcomings and 
modify the approach. 
A proposed part of open management of CBD 
stones has been intraoperative cholangiography (IOC). 
Open surgical or laparoscopic exploration of CBD is 
usually done in case of large CBD stones or if 
endoscopic approaches fail to extract the CBD stones. 
In some centers, IOC through T-tube is routinely 
performed in order to reduce the rate of retained stones 
(3-11). The main roles of T-tube are postoperative 
decompression of biliary tract, visualization of CBD 
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and availability to extract retained stones (12-14). The 
frequency of retained stones after IOC is reported to be 
up to 15 % in different studies (15-20). 
The efficacy of IOC for detecting retained stones is 
well established (21, 22); however recent studies debate 
on necessity of performing IOC routinely after 
laparoscopic cholecystectomy (4-11, 23-29). These 
studies discuss its benefit over other techniques such as 
intraoperative laparoscopic sonography or 
simultaneous intraoperative ERCP (30).  
This study aimed to determine the rate of retained 
stone in a series of patients with surgical CBD 
exploration without IOC. We also compared our 
findings with existing data from other series with or 
without IOC to discuss about the necessity of this 
intraoperative diagnostic procedure.  
Materials and Methods  
We performed a retrospective chart review of 399 
patients who underwent open surgical CBD exploration 
between April 2007 and June 2012 in Shariati Hospital, 
tertiary care center affiliated to Tehran University of 
Medical Sciences (Tehran, Iran). We excluded 7 
patients with ultimate diagnoses other than stone such 
as Ascaris lumbricoides, hydatid daughter cysts, 
tumoral obstruction or stricture and ampullary 
carcinoma. .  
Indications of surgical exploration in these patients 
included: 1) Failure of ERCP and ES, 2) ERCP was not 
indicated due to large diameter of CBD stone(s) in 
preoperative evaluations like endoscopic ultrasound 
(EUS) or magnetic resonance 
cholangiopancreatography (MRCP), 3) The presence of 
moderate to severe pancreatitis with potential risk of 
aggravating pancreatitis by ERCP, 4) Emergent cases 
with acute and severe cholangitis with hemodynamic 
instability that could not tolerate the endoscopic 
procedure and mandated emergent surgical exploration. 
Most of the failed ERCP+ES attempts were due to 
multiple, large size (stones>2 cm) or impacted CBD 
stones. 
Diagnosis of CBD stone was based on clinical 
presentation and laboratory tests followed by imaging 
techniques. Patients with acute cholangitis or 
pancreatitis presented with abdominal pain and/or 
fever, intermittent or constant obstructive jaundice, 
elevated white blood cell count, liver enzymes or serum 
amylase. Transabdominal ultrasonography (TUS) was 
performed for all patients. For elective patients, EUS 
was requested. Patients with negative TUS and EUS but 
still with high degree of suspicion for CBD stone 
underwent MRCP. Finally, decision for ERCP+ES was 
made according to the results of EUS or MRCP. 
Patients with acute pancreatitis were observed with 
non-surgical management until the acute pancreatitis 
symptoms subsided and then these group of patients 
underwent elective ERCP+ES if EUS did prove a CBD 
stone. However, patients with mild pancreatitis and 
concomitant acute cholangitis underwent emergent 
ERCP+ES. Patients with cholangitis and acute 
necrotizing pancreatitis, according to laboratory tests, 
TUS, and Computed tomography (CT) scan results, 
were considered for emergent surgical operation. 
Collected data included comorbidities (consisted of 
hypertension (HTN), diabetes mellitus (DM), chronic 
obstructive pulmonary disease (COPD), ischemic heart 
disease (IHD) and miscellaneous), size of stones 
according to MRCP or EUS, types of surgery, 
postoperative T-tube cholangiography results, length of 
hospitalization, ICU admission, postoperative 
mortality. 
Antibiotic therapy was started for acute cholangitis 
with Ceftriaxone (1gr/IV/BID) and Metronidazole (500 
mg/IV/TID) after admission. 
Management in elective operations was based on 
CBD diameter, which was determined by preoperative 
imaging, and intraoperative evaluation. In elective 
operations, CBD exploration and T-tube placement 
were performed when CBD diameter was less than 
12mm. Biliary-enteric anastomosis
(choledochoduodenostomy or choledochojejunostomy) 
was considered if CBD diameter was more than 12 mm. 
CBD exploration and T-tube placement was 
performed after complete stone extraction. Complete 
stone extraction was performed by 1) washing out the 
CBD and proximal ducts using Nelaton Catheter and 
Saline, 2) exploring proximal and distal ducts using 
straight and curved Randall stone forceps, and 3) 
passing the appropriate size dilator through left and 
right hepatic duct and sphincter of Oddi. Appropriate 
size T-tube (12-16 French) was used based on the CBD 
diameter. Antibiotic therapy was discontinued after 5-7 
days in emergent operations and after 24 hours in 
elective surgeries. 
We did not perform IOC after T-tube placement, 
taking into consideration reducing operation time and 
relying on complete intraoperative evaluation of biliary 
tree using saline flashing, stone forceps, and biliary 
tract dilators. 
T-tube cholangiography was performed 7-8 days
after surgery and patients with retained stones were 
managed with ERCP+ES for stone removal. T-tube was 
removed on 14th postoperative day in all patients. 
Data were analyzed using SPSS for windows 
(version 20; SPSS Inc., Chicago, IL, USA). 
Quantitative variables, mean, standard deviation and 
ranges were calculated, and reported. Continuous data 
with normal distribution and without normal 
distribution were tested by student t-test and Mann-
Whitney U-test respectively. We analyzed qualitative 
data using Chi-square test. P-values < 0.05 were 
considered statistically significant. 
Results 
Of 392 patients with CBD exploration, 196 (50%) 
were male. The mean (SD) age of patients was 
59.3±14.7 years (range: 23 to 85 years).  
In all patients stones were detected during the 
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surgery. A number of 177 (45.2%) patients underwent 
elective biliary-enteric anastomosis and 215 (54.8%) 
CBD exploration with T-tube placement. Sixty six 
(30.7%) patients with T-tube placement had emergent 
operations and 149 (69.3%) elective operations. 
Among emergent cases, 50 operations were due to 
cholangitis and 16 because of acute biliary pancreatitis. 
Cholecystectomy was performed simultaneously with 
CBD exploration in 263 patients (67.1%) and 129 
patients (32.9%) had history of previous 
cholecystectomy. 
Initial ERCP+ES had been failed in 149 patients 
who had been presented with acute cholangitis or acute 
biliary pancreatitis (121 cholangitis+ 28 pancreatis). In 
66 (44.3%) cases of these patients, emergent CBD 
exploration + T-tube placement was performed and in 
the other 83 (55.7%) patients, who responded to initial 
antibiotic therapy, elective surgery was performed (T-
tube placement in 33 patients and biliary-enteric 
anastomosis in 50 patients).  
Twenty-eight patients (7.1%) presented mainly 
with acute pancreatitis. Twelve of them finally 
underwent elective operation (6 T-tube placement and 
6 biliary-enteric anastomoses). Other 16 patients 
underwent emergent CBD exploration and T-tube 
placement due to the presence of severe pancreatitis 
and concomitant cholangitis.  
Table 1 shows the comparison between patients 
with T-tube placement and biliary-enteric anastomosis. 
Average hospital stay for patients with biliary-enteric 
anastomosis was 14.3±10.7 days, and for patients with 
T-tube placement it was 11.0±6.6 days (p<0.01). The 
mean size of the largest stone was 12.5 ± 3.5 mm and 
13.8 ± 3.8 mm in patients with T-tube placement and 
biliary-enteric anastomosis respectively (p>0.05). 
Patients with biliary-enteric anastomosis had a mean 
CBD diameter of 16.3 ± 3.7 mm and in those who 
underwent T-tube insertion mean CBD diameter was 
12.8 ± 2.5 mm (p<0.05).
Four deaths (1.8 %) occurred in T-tube inserted 
patients. Two of them were due to sepsis in the setting 
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of severe infected necrotizing pancreatitis which did 
not responded to T-tube placement and multiple 
debridement and drainage of pancreas. Other two 
patients experienced multiorgan failure due to the 
severe septic shock following acute cholangitis which 
did not respond to CBD drainage and broad spectrum 
antibiotic therapy. 
Mean age of patients who admitted to ICU after 
surgery was 67.6 years and for patients without ICU 
admission, was 56.9 years, and this difference between 
two groups was significant (p<0.05). 
Some 127 (32.4%) of 392 patients had major 
comorbidities beside CBD stone. The mean age of these 
patients was 62.2 years and those without comorbidities 
was 57.9 years, and the difference was statistically 
significant (p<0.05). 82 (64.6%) of these patients 
underwent T-tube insertion, including 37 emergent 
operations.  
Postoperative cholangiography though T-tube 
revealed that retained stones was present in six cases 
(2.8%) of 215 patients with T-tube placement. All of 
these patients were treated successfully by 
postoperative ERCP+ES with no further complication.  
In the follow-up with a median of 14 months, none 
of the patients showed any sign of retained stone, 
stricture, or any complication related to their biliary 
surgery. 
Our management protocol for patients with CBD 
stones was based on patients' condition that may be an 
emergent condition with acute cholangitis (with or 
without pancreatitis) or an elective situation, and 
diameter of CBD at the time of surgery. We performed 
CBD exploration and T-tube placement without 
intraoperative T-tube cholangiography in 215 patients 
and retained stones were seen only in 6 cases (2.8%), 
which were managed through postoperative ERCP+ES. 
Table 2 shows results of some studies on patients 
with CBD stone.  These studies represent comparable 
outcomes (rate of retained stone) when performing IOC 
or omitting it in the process of managing CBD stones 
(Table 2).  
 
Table 1. Descriptive and comparative data of Patients with T-tube placement and biliary-enteric anastomosis 
Variables T-tube placement 
n=215 
Biliary- enteric 
anastomosis 
n = 177 
Age, mean ± SD, y 55.8±15.0 63.5±13.2 
Male Gender, n (%) 111(51.6%) 85(48.0%) 
History of cholecystectomy, n (%) 63 (29.3%) 66(37.3%) 
 
Main Clinical Presentation 
 
Cholangitis, n (%) 83(38.6%) 38(21.7%) 
Pancreatitis, n (%) 
Cholecystitis, n (%) 
14(6.5%) 
86(40.0%) 
14(7.9%) 
46(26.0%) 
Chronic abdominal pain, n (%) 32 (14.9) 79 (44.6%) 
Major Comorbidities, n (%) 82(38.1%) 45(25.4%) 
Hospital stay, mean ± SD, d 11.0±6.6 14.3±10.7 
ICU admission, n (%) 51(%) 35(%) 
CBD diameter*, mean ± SD, mm 
Size of the largest stone, mean ± SD, mm 
12.8±2.5 
12.5±3.5 
16.3±3.7 
13.8±3.8 
*p < 0.05
Table 2. Results of some studies on patients with CBD stone.
Pesce A et al1  2012 1100 laparoscopic without 4(0.36%) Italy 
Ammori et al25 2012 717 laparoscopic without 3(0.4%) UK 
Mostafa A et al7 2011 2714 laparoscopic without 6(0.22%) Egypt 
Al-Qahtani et al6 2011 116 open without 5(4.3%) Saudi Arabia 
Khan et al26 2011 190 laparoscopic With/without 0/0 UK 
James Horwood et al27 2010 501: 166/335 laparoscopic With/without 4(2.4%)/3(0.9%) UK 
Amott et al8 2005 303 laparoscopic with 8(2.64%) Australia 
Singh G et al10 2000 134 open with 2(1.5%) India 
Nies et al28 1997 275: 138/137 open With/without 0/4(2.9%) Germany 
Sharma et al9 1993 167 open with 0 UK 
Hauer-jensen et al29 1993 280 open With/without 0/0 Norway 
Present study 2012 215 open without 6(2.8%) Iran 
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The frequency of retained CBD stones varies from 
3% to 15% in patients undergoing CBD exploration 
depending on the type of procedure (3,6,15,20).  
Two types of interventions have significant roles in 
managing CBD stones: ERCP+ES and surgical CBD 
exploration. During recent decades ERCP and 
endoscopic sphincterotomy (ES) has gained wide 
acceptance as an effective alternative to other 
techniques in management of CBD stones (31-33). 
Stone recurrence rate after ES, ranged between 6% and 
21%, as has been reported in both Western and Asian 
cohort studies with long-term follow-ups (34-37); 
however rate of retained stones after sphincterotomy 
without subsequent cholecystectomy was more than 20 
% (18). 
In our center, we usually perform open exploration 
of CBD when ERCP and ES has been failed. This may 
raise the question that why other alternatives such as 
laparoscopic exploration are not elected after ERCP 
failure. To proceed to laparoscopic surgery, one must 
be cognizant of the resources and required expertise. 
Laparoscopic CBD exploration and stone removal are 
technically challenging and only skilled laparoscopic 
surgeons can readily accomplish this operation when 
appropriate instruments are available. Although we 
perform laparoscopic cholecystectomy in our center for 
most of patients with gall bladder stone or cholecystitis, 
however we have not required facilities for 
laparoscopic CBD exploration yet, especially in 
patients who had previous upper abdominal operations. 
The 32.9% rate of previous history of cholecystectomy 
and relatively high incidence of co-morbidities in our 
patients were challenges against performing 
laparoscopic exploration of the CBD that could cause 
more extended time of operation as well. 
Since its introduction, the T-tube has had an 
important role in biliary surgery. The rationale for the 
use of T-tube is to ensure biliary decompression, to 
permit the healing of choledochotomy and to create a 
track lined by fibrous tissue for later imaging and 
probable percutaneous stone extraction (12-14,38). 
However the latter has been under question after 
widespread acceptance of endoscopic stone extraction 
techniques in the treatment of residual bile duct stones 
in which T-tube can potentially poses a mechanical 
barrier to spontaneous passage of stones, basketing or 
balloon catheters through ERCP+ES in patients who 
had CBD exploration and T-tube in place (3). 
Intraoperative cholangiography (IOC) during 
laparoscopic cholecystectomy is generally accepted as 
an integrated part of CBD assessment. The main reason 
for studying bile duct is to seek for common bile duct 
stones and assessing anatomy of CBD. After 
identifying stones within cystic duct using IOC, in 
centers which have related experience and facilities, 
appropriate stone extraction method is used including 
laparoscopic or open bile duct exploration, 
intraoperative ERCP, or postoperative ERCP and ES 
(23). In a systematic review by Ford, he reviewed the 
randomized clinical trials about IOC performed to 
detect choledocholithiasis and identify or prevent bile 
duct injury. He concluded there was no robust evidence 
to support or abandon the use of IOC to prevent retained 
CBD stones or bile duct injury (5). In another study 
Hauer-Jensen assessed the value of routine IOC during 
cholecystectomy for gallstone disease, and concluded 
that when clinical criteria suggest the presence of CBD 
abnormalities, IOC should be performed (29).  
On the other hand some studies showed that IOC 
after T-tube insertion is not required to be performed 
after open CBD exploration or laparoscopic 
cholecystectomy routinely and does not affect outcome 
of surgery in relation to the frequency of retained stones 
and CBD injury (6,7,10,11,25-29). In a prospective 
study by Singh to determine whether to perform 
selective or routine IOC in patients undergoing open 
cholecystectomy for gallstones diseases, he concluded 
that routine IOC during cholecystectomy is not 
essential for the prevention of retained stones (10). In a 
retrospective study by Pesce to review the results of 
1100 patients who underwent laparoscopic 
cholecystectomy (LC) without the use of IOC in 
relation to biliary complications, he concluded that LC 
can be performed safely without IOC (11). 
According to our protocol, T-tube placement was 
performed in emergent operations because of acute 
cholangitis (with or without pancreatitis). In elective 
cases with choledocholithiasis, those who had CBD 
diameter of less than 12 mm and in some patients who 
had high risk for general anesthesia and poor clinical 
conditions. Therefore, we considered the importance of 
reducing the operation time and low probability of 
retained stones after exploration of CBD and we 
preferred not to perform IOC after T-tube placement. 
Al-Qahtani in a retrospective study determined the 
long-term outcome of cholecystectomy without IOC in 
patients recovering from acute gallstone pancreatitis 
with normal liver function test and imaging. In this 
study the incidence of bilio-pancreatic complications 
from unsuspected CBD stones in the patients who 
underwent cholecystectomy without IOC was very low. 
He concluded that a routine IOC in these patients can 
be omitted safely (6).  
Intraoperative ultrasound or choledochoscopy was 
not an option in our protocol because of lack of 
equipment; although they cannot definitely rule out the 
risk of retained stones and therefore, the indication for 
T-tube placement persists after performing these
techniques.
Frequency of retained stone in our patients (with T-
tube insertion without performing routine IOC through 
T-tubes) was 2.8%, which is acceptable and
comparable with other studies (Table 2). In a
prospective cohort study by Amott, he compared the
policies of routine and selective IOC, and concluded
that there was no difference between them in relation to
retained CBD stones (2.64%), operating times, and
CBD injury (8). Stone basketing and extraction with
ERCP+ES postoperatively was completely successful
in those patients; similar to our study.
Mostafa in a retrospective study reviewed the 
results of a relatively large multi- center series of LC 
Outcome of CBD exploration without IOC 
without IOC with regard to major biliary 
complications. He concluded that LC can be performed 
safely without doing IOC with acceptable low rates of 
biliary complications (7).  
A final consideration concerns the risk of 
postoperative ES failure and the possible need for a 
second operation to clear the bile duct (23). Re-
exploration of CBD carries a postoperative mortality 
varying from 3% to 28% and morbidity from 20% to 
30% (41, 42). It also might be followed by failure of 
complete bile duct clearance (43). In this study, we did 
not have any patient who has been required re-
exploration of CBD due to postoperative ERCP+ES 
failure. It should be mentioned that after open CBD 
exploration and T-tube placement, if any residual stone 
has been retained, it is most probably small enough to 
be extracted through ERCP+ES.   
Our protocol for CBD stone management in this 
study, leads to a stepwise removal of CBD stone: 1) 
ERCP+ES, 2) open CBD exploration in case of ERCP 
failure, 3) postoperative T-tube cholangiography, after 
one week, and 4) if required, the secondary ERCP to 
extract the retained stones. These treatment protocol 
permits a safe endoscopic management of retained 
stones, since all patients have previously underwent 
CBD exploration, therefore the retained stones are less 
likely to be large or impacted, and  can be easily 
extracted by ERCP+ ES, and if necessary, using stone 
basketing and other ERCP techniques.  
False positive results and an increase in operation 
time besides risks of morbidity and mortality makes the 
value of IOC more and more questionable (44). In 
2013, AL-Jiffry et al proposed an algorithm, and 
patients who required IOC were selected based on the 
following inclusion criteria: abnormal liver function 
tests (LFT) with normal preoperative ultrasonography 
(US) and MRCP, and patients with abnormal US and 
CBD dilatation when ERCP failed. Indeed, for patients 
who had normal LFT, IOC has not been performed in 
that study (45). 
Laparoscopic subtotal cholecystectomy (LSC) for 
cholecystits was discussed in literature with or without 
IOC. Kuwabara et al reported similar hospital stay and 
operation time for LSC with IOC in comparison to LSC 
without IOC. They suggested the aid of IOC along with 
LSC as a good and reasonable procedure (46). 
Postoperative endoscopic stone removal in our 
approach did not carry any risk to the patients. previous 
attempts to extract CBD stones through ES, smaller size 
of retained stones, and presence of reliable imaging of 
biliary tree (through postoperative T-tube 
cholangiography) are the factors in favor of an easier 
secondary access to biliary tree in such cases. This 
subject was confirmed in our study and all patients with 
retained stones (6 out of 215 patients) were managed 
successfully with secondary ERCP and stone extraction 
without facing any complication or further need to 
surgical procedures. On the other hand, in cases with 
retained stone ERCP was performed after one week of 
T-tube insertion, then after the second week we 
removed the T-tube. If we want to extract the stone
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through tract of T-tube then we should wait until the 
fourth week and this is a longer period with probable 
morbidities and more challenging stone extraction 
through T-tube tract. 
Conclusion 
The present study discusses about the role of IOC 
through T-tube that can detects bile duct retained 
stones; however there remains risk of retained stone 
beside the extension of operation time, therefore it is 
not necessary that IOC be routinely performed for this 
purpose and we can select patients who need and could 
benefit from this procedure. This approach can 
decrease the operation time while not affecting the 
outcome in relation to rate of retained stones. 
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